Use of an implantable drug delivery system for refractory chronic sickle cell pain

American Journal of Hematology

Volumn 78, Issue 2, 2005, Pages 153-154

  Smith, Thomas J ^a,b   Coyne, Patrick J ^a   Smith, Wally R ^a   Roberts, John D ^a   Smith, Virginia ^a  

^a Virginia Cmw Univ Medical Center   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Chronic sickle cell anemia; IDDS; Implantable devices; Intraspinal therapy; Intrathecal therapy; Opioids; Pain

Indexed keywords

FENTANYL; HYDROMORPHONE; MORPHINE; OXYCODONE;

ADULT; ANALGESIA; ANOREXIA; ARTICLE; BONE PAIN; CANCER PAIN; CASE REPORT; CONSTIPATION; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; IMPLANT; INTERMETHOD COMPARISON; NAUSEA; PRIORITY JOURNAL; SEDATION; SICKLE CELL ANEMIA; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

ADULT; ANEMIA, SICKLE CELL; CHRONIC DISEASE; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MIDDLE AGED; NARCOTICS; PAIN; SALVAGE THERAPY;

EID: 13244275114     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20252     Document Type: Article

References (6)

1. Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med 1992;116:364-368.
2. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KL, Grond S. Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001;93:247-257.
3. Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 2001;19:4275-4279.
4. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-4049.
5. Yaster M, Tobin JR, Billett C, Casella JF, Dover G: Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Pediatrics 1994;93:310-315.
6. Winkmuller M, Winkmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-467.